Megan Lerner to Glioblastoma
This is a "connection" page, showing publications Megan Lerner has written about Glioblastoma.
Connection Strength
0.527
-
XRN2 Is Required for Cell Motility and Invasion in Glioblastomas. Cells. 2022 04 28; 11(9).
Score: 0.187
-
A tale of two multi-focal therapies for glioblastoma: An antibody targeting ELTD1 and nitrone-based OKN-007. J Cell Mol Med. 2022 01; 26(2):570-582.
Score: 0.182
-
Optimized monoclonal antibody treatment against ELTD1 for GBM in a G55 xenograft mouse model. J Cell Mol Med. 2020 01; 24(2):1738-1749.
Score: 0.159